Company Filing History:
Years Active: 2005-2008
Title: Innovations by Chris Clendening
Introduction
Chris Clendening is an accomplished inventor based in Cleves, Ohio, known for his contributions to medical technology. He holds two patents that focus on innovative solutions for women's health and osteoporosis treatment. His work exemplifies the intersection of healthcare and technology, aiming to improve patient outcomes through targeted delivery systems.
Latest Patents
One of Clendening's latest patents is for a medicated tampon designed to deliver therapeutic agents. This invention includes a tampon body with a distal end and a dosage form affixed to it, which contains a formulation with a therapeutic agent. The dosage form is composed of multiple layers, enhancing its effectiveness. Additionally, he has developed a method for manufacturing this medicated tampon, which involves creating the tampon body, producing the layered dosage form, and affixing it to the tampon body.
Another significant patent focuses on formulations for transmucosal vaginal delivery of bisphosphonates. This invention includes devices and methods for delivering bisphosphonates directly to the systemic circulation through a vaginal device. The targeted delivery aims to treat osteoporosis and related bone diseases by preventing bone breakdown and loss of mass and strength through intravaginal administration.
Career Highlights
Throughout his career, Clendening has worked with notable companies such as Kimberly-Clark Worldwide, Inc. and UMD, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical devices and formulations.
Collaborations
Clendening has collaborated with professionals like Giovanni M. Pauletti and Steven Craig Gehling. These partnerships have likely enriched his work and led to advancements in his inventions.
Conclusion
Chris Clendening's innovative patents reflect his commitment to improving healthcare solutions. His work in developing medicated tampons and bisphosphonate delivery systems showcases the potential of targeted therapies in enhancing patient care.